[Genetically dependent variability of drug effects].
D000743:Anemia, Hemolytic / Q000139:chemically induced; D000768:Anesthesia, General / Q000009:adverse effects; D000777:Anesthetics / Q000009:adverse effects; D000818:Animals; D000983:Antipyrine / Q000378:metabolism; D001049:Apnea / Q000139:chemically induced; D001285:Atropine / Q000494:pharmacology; D001831:Body Temperature / Q000187:drug effects; D003374:Coumarins / Q000494:pharmacology; D003490:Cyanosis / Q000139:chemically induced; D003677:Deficiency Diseases / Q000097:blood; D003907:Dexamethasone / Q000494:pharmacology; D004285:Dogs; D004361:Drug Tolerance; D004798:Enzymes / Q000378:metabolism; D005260:Female; D005954:Glucosephosphate Dehydrogenase / Q000097:blood; D006801:Humans; D007429:Intraocular Pressure / Q000187:drug effects; D007539:Isonicotinic Acids / Q000378:metabolism; D008297:Male; D008614:Meperidine / Q000378:metabolism; D051379:Mice; D010113:Oxyphenbutazone / Q000378:metabolism; D010597:Pharmacogenetics; D010615:Phenacetin / Q000009:adverse effects; D010653:Phenylbutazone / Q000378:metabolism; D010672:Phenytoin / Q000009:adverse effects / Q000378:metabolism; D011506:Proteins / Q000378:metabolism; D011817:Rabbits; D051381:Rats; D013390:Succinylcholine / Q000009:adverse effects
D000777:Anesthetics; D003374:Coumarins; D004798:Enzymes; D007539:Isonicotinic Acids; D011506:Proteins; D010672:Phenytoin; D001285:Atropine; D003907:Dexamethasone; D008614:Meperidine; D005954:Glucosephosphate Dehydrogenase; D010615:Phenacetin; D010653:Phenylbutazone; D010113:Oxyphenbutazone; D013390:Succinylcholine; D000983:Antipyrine
Genetisch bedingte Variabilität der Arzneimittelwirkung.